Wrighton-Smith Peter

Avg. Two Year Performance

No purchase track record
9% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return20%22%18%0%0%
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return5%6%13%13%9%
Sale Success Rate8 of 125 of 128 of 1210 of 124 of 12
Drugs » Diagnostic Substances

Chief Executive Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--